Inspire Medical Systems, Inc. (INSP)
| Market Cap | 2.22B |
| Revenue (ttm) | 861.31M |
| Net Income (ttm) | 53.12M |
| Shares Out | 29.57M |
| EPS (ttm) | 1.74 |
| PE Ratio | 43.14 |
| Forward PE | 93.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,482,917 |
| Open | 80.20 |
| Previous Close | 80.14 |
| Day's Range | 75.17 - 80.97 |
| 52-Week Range | 70.77 - 216.01 |
| Beta | 1.16 |
| Analysts | Buy |
| Price Target | 154.00 (+104.87%) |
| Earnings Date | Nov 3, 2025 |
About INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $154.0, which is an increase of 104.87% from the latest price.
News
BAK Investors Have Opportunity to Join Braskem S.A. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $INSP--BAK Investors Have Opportunity to Join Braskem S.A. Fraud Investigation with the Schall Law Firm.
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima...
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2025 after the close of trading on Monday, Nove...
Inspire Medical Systems, Inc. (INSP) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Inspire Medical Systems, Inc. (NYSE:INSP) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 11:00 AM EDT Company Participants Carlton Weatherby - Chief Strategy and Growth Officer ...
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima...
Inspire Medical: Hiccups For The Sleep Business
Inspire Medical Systems faced a major setback after delays in the Inspire V launch, leading to slashed guidance and a sharp share price drop. Despite near-term volatility and margin pressure, the comp...
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima...
ALGN Investors Have Opportunity to Join Align Technology, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $INSP--ALGN Investors Have Opportunity to Join Align Technology, Inc. Fraud Investigation with the Schall Law Firm.
INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES , Aug. 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Inspire Medical Syst...
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of in...
Baron Discovery Fund Q2 2025: Winners And Setbacks Shaping The Portfolio
Kratos Defense, Montrose Environmental, and Karman Holdings drove strong quarterly performance, benefiting from secular tailwinds and robust demand in defense and environmental sectors. We see Kratos ...
Inspire Medical Stock Strays Off Course Amid Structural Setback
Inspire Medical Systems INSP iStocks currently in Phase 10 of its 18-phase cycle under the Adhishthana framework. Unfortunately for investors, the stock has broken below a key structural formation, th...
Inspire Medical Systems, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results
Inspire Medical Systems, Inc. INSP reported second-quarter results and cut its FY25 guidance below estimates on Monday.
Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React
Inspire Medical Systems, Inc. INSP stock is plunging after the company released its second-quarter earnings and cut its annual guidance.
Inspire Medical Systems, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation
Block & Leviton LLP is investigating Inspire Medical Systems (NYSE: INSP) for potential securities fraud. Investors who lost money should contact the firm.
Inspire Medical Systems, Ichor Holdings, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Conference Call August 4, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Richard J. Buchholz - Chief...
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of in...
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, Aug...
Inspire Medical Systems: Investors Should Sleep Better From Here Onwards
Inspire Medical's growth remains strong, with 2025 seen as a transition year due to the Inspire V launch, causing near-term margin volatility. Valuations look more attractive: shares trade at just 4x ...
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima...
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimal...
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students a...
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief...